Haleon PLC

Director's Dealing • Jul 21, 2022

National Storage Mechanism | Additional information

RNS Number : 3599T

Haleon PLC

21 July 2022

HALEON PLC 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

21 July 2022 

Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them. 

On 21 July 2022, Haleon plc (the "Company") received notification of the following transactions as detailed below. 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tobias Hestler
2	Reason for the notification
a)	Position/status	Chief Financial Officer - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction).
Identification code	GB00BMX86B70
b)	Nature of the transaction	Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		n/a	1,033
d)	Aggregated information
- Aggregated volume	1,033
- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Amy Landucci
2	Reason for the notification
a)	Position/status	Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction).
Identification code	GB00BMX86B70
b)	Nature of the transaction	Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		n/a	379
d)	Aggregated information
- Aggregated volume	379
- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bart Derde
2	Reason for the notification
a)	Position/status	Chief Supply Chain Officer - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction).
Identification code	GB00BMX86B70
b)	Nature of the transaction	Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		n/a	837
d)	Aggregated information
- Aggregated volume	837
- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jooyong Lee
2	Reason for the notification
a)	Position/status	Head of Strategy and Office of the CEO - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction).
Identification code	GB00BMX86B70
b)	Nature of the transaction	Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		n/a	386
d)	Aggregated information
- Aggregated volume	386
- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	London Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tamara Rogers
2	Reason for the notification
a)	Position/status	Chief Marketing Officer - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction).
Identification code	GB00BMX86B70
b)	Nature of the transaction	Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		n/a	937
d)	Aggregated information
- Aggregated volume	937
- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	London Stock Exchange

Amanda Mellor 

Company Secretary 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBLGDRUGDDGDB